Document Detail


Optimal volume of medicinal solution in the portable disposable infusion pump (SUREFUSER A) for FOLFOX6, FOLFIRI therapy of colorectal cancer patients (2nd report)-influence of temperature on outflow speed of the medicinal solution
MedLine Citation:
PMID:  20372010     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We formerly reported the most suitable volumes of medicinal solution for continuous 5FU infusion over 46 hours in the FOLFOX6 and FOLFIRI regimens, respectively, by analyzing the relation of the total volume of the medicinal solution in a portable disposable infusion pump (SUREFUSER A) and the duration of infusion using a regression analysis. A total infusion time of about 48 hours was obtained. As the ambient temperature increased, however, we noticed that the continuous 5FU infusion finished earlier than anticipated. Using an additional analysis, we found that not only the medicinal solution's original coefficient of viscosity, but also the ambient temperature influenced the duration of infusion. Here, we report that the speed of continuous 5FU infusion increases as the coefficient of viscosity decreases in response to increases in ambient temperature. Thus, the composition of medicinal solutions and the ambient temperature must be considered to ensure a correct duration of continuous infusion.
Authors:
Yoshinori Kawabata; Akiko Nakagawa
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan     Volume:  130     ISSN:  0031-6903     ISO Abbreviation:  Yakugaku Zasshi     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-07     Completed Date:  2010-05-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413613     Medline TA:  Yakugaku Zasshi     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  621-7     Citation Subset:  IM    
Affiliation:
Department of Pharmacy, Niigata Cancer Center Hospital, Niigata, Japan. mwoodmo@yahoo.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / administration & dosage,  therapeutic use*
Camptothecin / administration & dosage,  analogs & derivatives
Colorectal Neoplasms / drug therapy*
Disposable Equipment*
Fluorouracil / administration & dosage
Humans
Infusion Pumps*
Infusions, Intravenous
Leucovorin / administration & dosage
Organoplatinum Compounds / administration & dosage
Regression Analysis
Solutions
Temperature*
Time Factors
Viscosity
Chemical
Reg. No./Substance:
0/Folfox protocol; 0/IFL protocol; 0/Organoplatinum Compounds; 0/Solutions; 51-21-8/Fluorouracil; 58-05-9/Leucovorin; 7689-03-4/Camptothecin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Estimating Pediatric Doses of Drugs Metabolized by Cytochrome P450 (CYP) Isozymes, Based on Physiolo...
Next Document:  Investigation of bacterial diversity in membrane bioreactor and conventional activated sludge proces...